Double Medical Technology Inc. (SHE:002901)
40.53
-0.47 (-1.15%)
May 14, 2026, 3:04 PM CST
Double Medical Technology Revenue
Double Medical Technology had revenue of 641.50M CNY in the quarter ending March 31, 2026, with 16.56% growth. This brings the company's revenue in the last twelve months to 2.69B, up 19.19% year-over-year. In the year 2025, Double Medical Technology had annual revenue of 2.60B with 21.79% growth.
Revenue (ttm)
2.69B
Revenue Growth
+19.19%
P/S Ratio
6.15
Revenue / Employee
572.28K
Employees
4,704
Market Cap
16.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.60B | 465.30M | 21.79% |
| Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
| Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
| Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
| Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lepu Medical Technology (Beijing) | 6.42B |
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.78B |
| Cofoe Medical Technology | 3.66B |
| MGI Tech | 2.90B |
| Jafron Biomedical | 2.02B |
| MeHow Innovative | 1.73B |
| Shandong Weigao Orthopaedic Device | 1.53B |